Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
New report heralds a revolution in cancer R&D trends – and the sticker shock that comes with it
Endpoints
Thu, 06/1/17 - 09:02 am
cancer
R&D
drug development
Novartis sees gaps in cancer pipeline but is adamant it doesn’t need an I-O deal
Fierce Biotech
Thu, 06/1/17 - 09:01 am
Novartis
cancer
immuno-oncology
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy
Xconomy
Wed, 05/31/17 - 10:59 am
ASCO 2017
cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker
Endpoints
Wed, 05/24/17 - 10:59 am
Merck
Keytruda
FDA
biomarkers
cancer
Teva says it's eyeing a debt-cutting sale of its cancer meds
Fierce Pharma
Wed, 04/26/17 - 09:30 pm
Teva Pharmaceutical
M&A
cancer
Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact
Endpoints
Wed, 04/19/17 - 04:17 pm
Bristol-Myers Squibb
cancer
vaccines
Bavarian Nordic
Prostvac
Opdivo
Yervoy
Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO
Endpoints
Tue, 04/18/17 - 08:58 pm
G1 Therapeutics
IPOs
Pfizer
Novartis
Eli Lilly
cancer
R&D
The cost of cancer: new drugs show success at a steep price
Yahoo/Reuters
Mon, 04/3/17 - 09:13 am
cancer
Bristol-Myers Squibb
Merck
Roche
How AbbVie Is Attacking Tumors at Their Roots
Motley Fool
Wed, 03/29/17 - 09:06 am
AbbVie
solid tumors
cancer
stem cells
Stemcentrx
Rova-T
Cancer patients skipping medicines or delaying treatment due to high drug prices
Stat
Wed, 03/15/17 - 10:13 am
patients
oncology
cancer
drug pricing
Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK
Endpoints
Sat, 03/4/17 - 12:32 pm
Chi-Med
fruquintinib
oncology
cancer
China
MD Anderson Benches IBM Watson In Setback For Artificial Intelligence In Medicine
Forbes
Mon, 02/20/17 - 10:03 am
IBM
artificial intelligence
cancer
Watson
MD Anderson Cancer Center
5 trends being impacted by biomarkers
BioPharma Dive
Tue, 02/14/17 - 07:39 pm
biomarkers
precision medicine
combo trials
diagnostics
R&D
cancer
liquid biopsy
Most new, high-priced cancer drugs don’t even extend life for 10 weeks
ARS Technica, UK
Mon, 02/13/17 - 03:27 pm
cancer
oncology
Amgen, Immatics In Cancer Drug Partnership
Investopedia
Mon, 01/9/17 - 10:10 am
Amgen
Immatics
bispecific antibodies
R&D
cancer
A startup trying to get the human body to fight cancer just filed for an IPO
Yahoo/Business Insider
Tue, 01/3/17 - 11:39 am
cancer
IPOs
Jounce Therapeutics
Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer
Yahoo
Fri, 12/16/16 - 09:45 am
Ionis
AstraZeneca
AZD4785
KRAS
cancer
3 Big Advances In Cancer Treatment In 2016
Motley Fool
Mon, 12/12/16 - 09:24 am
cancer
Merck
Keytruda
Kite Pharma
KTE-C19
Ariad Pharmaceuticals
brigatinib
Study: IBM Watson agrees with cancer docs on treatment options 90% of the time
Fierce Biotech
Fri, 12/9/16 - 09:43 am
IBM
Watson Health
oncology
cancer
artificial intelligence
Merck Laughs Its Way To The Bank With Breakthrough Cancer Drug Keytruda
Seeking Alpha
Thu, 12/8/16 - 10:02 am
Merck
Keytruda
cancer
oncology
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »